• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ZLD

ZELIRA THERAPEUTICS LIMITED - Announcements

7.32% ! 38.0¢
Market Cap $4.520M  !

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

Announcements



ZLD Phase 1 Opioid Reduction Clinical Trial Fully EnrolledPRICE SENSITIVE27/02/20 download Created with Sketch. 160.74KB
ZLD Appendix 2A and Cleansing Notice19/02/20 download Created with Sketch. 478.66KB
ZLD Zelira Meets Primary Endpoints for Insomnia TrialPRICE SENSITIVE19/02/20 download Created with Sketch. 275.92KB
ZLD Trading HaltPRICE SENSITIVE17/02/20 download Created with Sketch. 228.76KB
ZLD Proposed issue of Securities - ZLD17/02/20 download Created with Sketch. 24.98KB
ZLD Capital Raising Update17/02/20 download Created with Sketch. 119.62KB
ZLD Expiry of unlisted options07/02/20 download Created with Sketch. 110.26KB
ZLD Cleansing Notice06/02/20 download Created with Sketch. 198.8KB
ZLD Appendix 2A06/02/20 download Created with Sketch. 273.82KB
ZLD Proposed issue of Securities - ZLD05/02/20 download Created with Sketch. 25.23KB
ZLD Zelira Successfully Completes Capital Raising of $4.6MPRICE SENSITIVE05/02/20 download Created with Sketch. 161.73KB
ZLD Trading HaltPRICE SENSITIVE03/02/20 download Created with Sketch. 192.45KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/01/20 download Created with Sketch. 207.02KB
ZLD December 2019 Quarterly ReportPRICE SENSITIVE31/01/20 download Created with Sketch. 126.51KB
ZLD Zelira to Collaborate with the Parkinsons FoundationPRICE SENSITIVE28/01/20 download Created with Sketch. 163.61KB
ZLD Ceasing to be a substantial holder17/01/20 download Created with Sketch. 150.39KB
ZLD Change in substantial holding10/01/20 download Created with Sketch. 386.3KB
ZLD Change of Director's Interest Notice x 302/01/20 download Created with Sketch. 250.96KB
ZLD Appendix 3B and Cleansing Notice02/01/20 download Created with Sketch. 478.06KB
ZLD Notification of Expiry of Unlisted Options02/01/20 download Created with Sketch. 173.61KB
ZLD Change of Director's Interest Notice x 323/12/19 download Created with Sketch. 304.66KB
ZLD Appendix 3B23/12/19 download Created with Sketch. 437.09KB
ZLD Last patient completes dosing in insomnia clinical trial17/12/19 download Created with Sketch. 133.56KB
ZLD Official name change to Zelira Therapeutics04/12/19 download Created with Sketch. 102.5KB
ZLD Initial Director's Interest Notice x 304/12/19 download Created with Sketch. 171.19KB
ZLD Zelira Therapeutics expands HOPE distribution in the U.S.APRICE SENSITIVE04/12/19 download Created with Sketch. 139.89KB
ZLD Final Director's Interest Notice02/12/19 download Created with Sketch. 210.27KB
ZLD Ilera Therapeutics Merger Completed and Board ChangesPRICE SENSITIVE02/12/19 download Created with Sketch. 165.2KB
ZLD New Constitution28/11/19 download Created with Sketch. 664.74KB
ZLD Results of Meeting28/11/19 download Created with Sketch. 223.04KB
ZLD 2019 AGM Chairman's Address28/11/19 download Created with Sketch. 110.83KB
ZLD Annual General Meeting Presentation 201928/11/19 download Created with Sketch. 6.37MB
ZLD Investor Presentation - Non-deal Roadshow25/11/19 download Created with Sketch. 6.35MB
ZLD Agreement with Health House to Distribute Zelda ProductsPRICE SENSITIVE21/11/19 download Created with Sketch. 212.12KB
ZLD Update on Global Launch Strategy for HOPE Range of Products20/11/19 download Created with Sketch. 136.88KB
ZLD Formulations to be supplied as part of CARE NSW trialPRICE SENSITIVE14/11/19 download Created with Sketch. 160.54KB
ZLD R&D Tax Incentive RefundPRICE SENSITIVE11/11/19 download Created with Sketch. 108.66KB
ZLD Zeldas Phase II Insomnia Clinical Trial Fully EnrolledPRICE SENSITIVE07/11/19 download Created with Sketch. 175.64KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/10/19 download Created with Sketch. 203.39KB
ZLD September 2019 Quarterly ReportPRICE SENSITIVE31/10/19 download Created with Sketch. 167.65KB
ZLD Notice of Annual General Meeting25/10/19 download Created with Sketch. 435.62KB
ZLD Becoming a substantial holder16/10/19 download Created with Sketch. 259.8KB
ZLD Zelira Transaction Investor Teleconference and Q&A15/10/19 download Created with Sketch. 172.89KB
ZLD Appendix 3B and Cleansing Notice10/10/19 download Created with Sketch. 649.03KB
ZLD Investor Presentation - Zelira - Non Deal Roadshow09/10/19 download Created with Sketch. 9.72MB
ZLD Zelda to merge with US-based Ilera TherapeuticsPRICE SENSITIVE09/10/19 download Created with Sketch. 223.68KB
ZLD Trading HaltPRICE SENSITIVE08/10/19 download Created with Sketch. 409.99KB
ZLD Pause in TradingPRICE SENSITIVE08/10/19 download Created with Sketch. 117.26KB
ZLD Appendix 3B27/09/19 download Created with Sketch. 370.57KB
ZLD Cancellation of Unlisted Options02/09/19 download Created with Sketch. 152.08KB
ZLD Appendix 4G30/08/19 download Created with Sketch. 161.13KB
ZLD Appendix 4E & Financial StatementsPRICE SENSITIVE30/08/19 download Created with Sketch. 1.81MB
ZLD Zeldas Autism Observational Study Recruits 100th ParticipantPRICE SENSITIVE22/08/19 download Created with Sketch. 135KB
ZLD June 2019 Quarterly ReportPRICE SENSITIVE31/07/19 download Created with Sketch. 154.04KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/07/19 download Created with Sketch. 203.12KB
ZLD US Non-deal Roadshow - Investor Presentation22/07/19 download Created with Sketch. 11.92MB
ZLD Appendix 3B and Cleansing Notice - Exercise of Options19/07/19 download Created with Sketch. 516KB
ZLD Zelda Collaborates with Emerald ClinicsPRICE SENSITIVE18/07/19 download Created with Sketch. 168.44KB
ZLD Response to ASX Price and Volume QueryPRICE SENSITIVE11/07/19 download Created with Sketch. 301.05KB
ZLD Investor Presentation - Non-deal Roadshow10/07/19 download Created with Sketch. 9.73MB
ZLD Zelda Granted Approval for Opioid Reduction TrialPRICE SENSITIVE02/07/19 download Created with Sketch. 163.14KB
ZLD Change in substantial holding11/06/19 download Created with Sketch. 155.05KB
ZLD Change of Director's Interest Notice x 311/06/19 download Created with Sketch. 233.28KB
ZLD Director Shareholding Changes and Strategic Investment11/06/19 download Created with Sketch. 162.73KB
ZLD Investor Presentation - Non-deal Roadshow13/05/19 download Created with Sketch. 11.43MB
ZLD R&D Tax Incentive RefundPRICE SENSITIVE09/05/19 download Created with Sketch. 133.86KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/04/19 download Created with Sketch. 178.66KB
ZLD March 2019 Quarterly ReportPRICE SENSITIVE30/04/19 download Created with Sketch. 125.03KB
ZLD Zelda Partners with Ilera HealthCarePRICE SENSITIVE12/03/19 download Created with Sketch. 168.8KB
ZLD Aus Patent For Novel Prognostic Marker for Breast CancerPRICE SENSITIVE06/03/19 download Created with Sketch. 171.55KB
ZLD Novel Cannabis Pathway for Treatment of Breast Cancer28/02/19 download Created with Sketch. 191.01KB
ZLD Appendix 4D & FY19 Interim Financial ReportPRICE SENSITIVE22/02/19 download Created with Sketch. 1.07MB
ZLD Appendix 3B19/02/19 download Created with Sketch. 342.53KB
ZLD Results of Meeting18/02/19 download Created with Sketch. 176.92KB
ZLD ZLD Engages ICCI for Clinical Trial and Regulatory Expertise12/02/19 download Created with Sketch. 173.77KB
ZLD Change of Director's Interest Notice05/02/19 download Created with Sketch. 185.76KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE30/01/19 download Created with Sketch. 160.1KB
ZLD December 2018 Quarterly Report and Board TransitionPRICE SENSITIVE30/01/19 download Created with Sketch. 199.72KB
ZLD Notice of General Meeting18/01/19 download Created with Sketch. 153.55KB
ZLD Appendix 3B16/01/19 download Created with Sketch. 344.47KB
ZLD Response to ASX Appendix 3Y Query16/01/19 download Created with Sketch. 298.8KB
ZLD Change in substantial holding14/01/19 download Created with Sketch. 162.18KB
ZLD Change of Director's Interest Notice14/01/19 download Created with Sketch. 184.59KB
ZLD Response to ASX Price and Volume QueryPRICE SENSITIVE08/01/19 download Created with Sketch. 297.5KB
ZLD Change of Director's Interest Notice14/12/18 download Created with Sketch. 185.64KB
ZLD Change of Director's Interest Notice07/12/18 download Created with Sketch. 197.17KB
ZLD ZLD to Invest in Development of Oral Spray FormulationsPRICE SENSITIVE06/12/18 download Created with Sketch. 165.27KB
ZLD SUD: SUDA Enters Agreement To Develop Cannabinoid SprayPRICE SENSITIVE06/12/18 download Created with Sketch. 157.53KB
ZLD Results of Meeting30/11/18 download Created with Sketch. 180.33KB
ZLD Annual General Meeting Presentation 201830/11/18 download Created with Sketch. 8.77MB
ZLD Investor Presentation - Non-deal Roadshow27/11/18 download Created with Sketch. 8.77MB
ZLD Opioid reduction clinical trial with St Vincent's HospitalPRICE SENSITIVE26/11/18 download Created with Sketch. 131.23KB
ZLD Appendix 3B22/11/18 download Created with Sketch. 336.16KB
ZLD Correction to Unlisted Option Expiry Date14/11/18 download Created with Sketch. 153.71KB
ZLD Release From Escrow and Founders Commitment Not to Sell07/11/18 download Created with Sketch. 163.35KB
ZLD Appendix 4C - quarterlyPRICE SENSITIVE31/10/18 download Created with Sketch. 160.02KB
ZLD September 2018 Quarterly ReportPRICE SENSITIVE31/10/18 download Created with Sketch. 228.73KB
ZLD Notice of Annual General Meeting29/10/18 download Created with Sketch. 217.92KB
ZLD Managing Director Remuneration Variation12/10/18 download Created with Sketch. 158.11KB
ZLD Zelda Focuses Clinical Trial ActivityPRICE SENSITIVE11/10/18 download Created with Sketch. 157.83KB
ZLD Phase 1 Opioid Reduction Clinical Trial Fully Enrolled
27/02/20PRICE SENSITIVE download Created with Sketch. 160.74KB
ZLD Appendix 2A and Cleansing Notice
19/02/20 download Created with Sketch. 478.66KB
ZLD Zelira Meets Primary Endpoints for Insomnia Trial
19/02/20PRICE SENSITIVE download Created with Sketch. 275.92KB
ZLD Trading Halt
17/02/20PRICE SENSITIVE download Created with Sketch. 228.76KB
ZLD Proposed issue of Securities - ZLD
17/02/20 download Created with Sketch. 24.98KB
ZLD Capital Raising Update
17/02/20 download Created with Sketch. 119.62KB
ZLD Expiry of unlisted options
07/02/20 download Created with Sketch. 110.26KB
ZLD Cleansing Notice
06/02/20 download Created with Sketch. 198.8KB
ZLD Appendix 2A
06/02/20 download Created with Sketch. 273.82KB
ZLD Proposed issue of Securities - ZLD
05/02/20 download Created with Sketch. 25.23KB
ZLD Zelira Successfully Completes Capital Raising of $4.6M
05/02/20PRICE SENSITIVE download Created with Sketch. 161.73KB
ZLD Trading Halt
03/02/20PRICE SENSITIVE download Created with Sketch. 192.45KB
ZLD Appendix 4C - quarterly
31/01/20PRICE SENSITIVE download Created with Sketch. 207.02KB
ZLD December 2019 Quarterly Report
31/01/20PRICE SENSITIVE download Created with Sketch. 126.51KB
ZLD Zelira to Collaborate with the Parkinsons Foundation
28/01/20PRICE SENSITIVE download Created with Sketch. 163.61KB
ZLD Ceasing to be a substantial holder
17/01/20 download Created with Sketch. 150.39KB
ZLD Change in substantial holding
10/01/20 download Created with Sketch. 386.3KB
ZLD Change of Director's Interest Notice x 3
02/01/20 download Created with Sketch. 250.96KB
ZLD Appendix 3B and Cleansing Notice
02/01/20 download Created with Sketch. 478.06KB
ZLD Notification of Expiry of Unlisted Options
02/01/20 download Created with Sketch. 173.61KB
ZLD Change of Director's Interest Notice x 3
23/12/19 download Created with Sketch. 304.66KB
ZLD Appendix 3B
23/12/19 download Created with Sketch. 437.09KB
ZLD Last patient completes dosing in insomnia clinical trial
17/12/19 download Created with Sketch. 133.56KB
ZLD Official name change to Zelira Therapeutics
04/12/19 download Created with Sketch. 102.5KB
ZLD Initial Director's Interest Notice x 3
04/12/19 download Created with Sketch. 171.19KB
ZLD Zelira Therapeutics expands HOPE distribution in the U.S.A
04/12/19PRICE SENSITIVE download Created with Sketch. 139.89KB
ZLD Final Director's Interest Notice
02/12/19 download Created with Sketch. 210.27KB
ZLD Ilera Therapeutics Merger Completed and Board Changes
02/12/19PRICE SENSITIVE download Created with Sketch. 165.2KB
ZLD New Constitution
28/11/19 download Created with Sketch. 664.74KB
ZLD Results of Meeting
28/11/19 download Created with Sketch. 223.04KB
ZLD 2019 AGM Chairman's Address
28/11/19 download Created with Sketch. 110.83KB
ZLD Annual General Meeting Presentation 2019
28/11/19 download Created with Sketch. 6.37MB
ZLD Investor Presentation - Non-deal Roadshow
25/11/19 download Created with Sketch. 6.35MB
ZLD Agreement with Health House to Distribute Zelda Products
21/11/19PRICE SENSITIVE download Created with Sketch. 212.12KB
ZLD Update on Global Launch Strategy for HOPE Range of Products
20/11/19 download Created with Sketch. 136.88KB
ZLD Formulations to be supplied as part of CARE NSW trial
14/11/19PRICE SENSITIVE download Created with Sketch. 160.54KB
ZLD R&D Tax Incentive Refund
11/11/19PRICE SENSITIVE download Created with Sketch. 108.66KB
ZLD Zeldas Phase II Insomnia Clinical Trial Fully Enrolled
07/11/19PRICE SENSITIVE download Created with Sketch. 175.64KB
ZLD Appendix 4C - quarterly
31/10/19PRICE SENSITIVE download Created with Sketch. 203.39KB
ZLD September 2019 Quarterly Report
31/10/19PRICE SENSITIVE download Created with Sketch. 167.65KB
ZLD Notice of Annual General Meeting
25/10/19 download Created with Sketch. 435.62KB
ZLD Becoming a substantial holder
16/10/19 download Created with Sketch. 259.8KB
ZLD Zelira Transaction Investor Teleconference and Q&A
15/10/19 download Created with Sketch. 172.89KB
ZLD Appendix 3B and Cleansing Notice
10/10/19 download Created with Sketch. 649.03KB
ZLD Investor Presentation - Zelira - Non Deal Roadshow
09/10/19 download Created with Sketch. 9.72MB
ZLD Zelda to merge with US-based Ilera Therapeutics
09/10/19PRICE SENSITIVE download Created with Sketch. 223.68KB
ZLD Trading Halt
08/10/19PRICE SENSITIVE download Created with Sketch. 409.99KB
ZLD Pause in Trading
08/10/19PRICE SENSITIVE download Created with Sketch. 117.26KB
ZLD Appendix 3B
27/09/19 download Created with Sketch. 370.57KB
ZLD Cancellation of Unlisted Options
02/09/19 download Created with Sketch. 152.08KB
ZLD Appendix 4G
30/08/19 download Created with Sketch. 161.13KB
ZLD Appendix 4E & Financial Statements
30/08/19PRICE SENSITIVE download Created with Sketch. 1.81MB
ZLD Zeldas Autism Observational Study Recruits 100th Participant
22/08/19PRICE SENSITIVE download Created with Sketch. 135KB
ZLD June 2019 Quarterly Report
31/07/19PRICE SENSITIVE download Created with Sketch. 154.04KB
ZLD Appendix 4C - quarterly
31/07/19PRICE SENSITIVE download Created with Sketch. 203.12KB
ZLD US Non-deal Roadshow - Investor Presentation
22/07/19 download Created with Sketch. 11.92MB
ZLD Appendix 3B and Cleansing Notice - Exercise of Options
19/07/19 download Created with Sketch. 516KB
ZLD Zelda Collaborates with Emerald Clinics
18/07/19PRICE SENSITIVE download Created with Sketch. 168.44KB
ZLD Response to ASX Price and Volume Query
11/07/19PRICE SENSITIVE download Created with Sketch. 301.05KB
ZLD Investor Presentation - Non-deal Roadshow
10/07/19 download Created with Sketch. 9.73MB
ZLD Zelda Granted Approval for Opioid Reduction Trial
02/07/19PRICE SENSITIVE download Created with Sketch. 163.14KB
ZLD Change in substantial holding
11/06/19 download Created with Sketch. 155.05KB
ZLD Change of Director's Interest Notice x 3
11/06/19 download Created with Sketch. 233.28KB
ZLD Director Shareholding Changes and Strategic Investment
11/06/19 download Created with Sketch. 162.73KB
ZLD Investor Presentation - Non-deal Roadshow
13/05/19 download Created with Sketch. 11.43MB
ZLD R&D Tax Incentive Refund
09/05/19PRICE SENSITIVE download Created with Sketch. 133.86KB
ZLD Appendix 4C - quarterly
30/04/19PRICE SENSITIVE download Created with Sketch. 178.66KB
ZLD March 2019 Quarterly Report
30/04/19PRICE SENSITIVE download Created with Sketch. 125.03KB
ZLD Zelda Partners with Ilera HealthCare
12/03/19PRICE SENSITIVE download Created with Sketch. 168.8KB
ZLD Aus Patent For Novel Prognostic Marker for Breast Cancer
06/03/19PRICE SENSITIVE download Created with Sketch. 171.55KB
ZLD Novel Cannabis Pathway for Treatment of Breast Cancer
28/02/19 download Created with Sketch. 191.01KB
ZLD Appendix 4D & FY19 Interim Financial Report
22/02/19PRICE SENSITIVE download Created with Sketch. 1.07MB
ZLD Appendix 3B
19/02/19 download Created with Sketch. 342.53KB
ZLD Results of Meeting
18/02/19 download Created with Sketch. 176.92KB
ZLD ZLD Engages ICCI for Clinical Trial and Regulatory Expertise
12/02/19 download Created with Sketch. 173.77KB
ZLD Change of Director's Interest Notice
05/02/19 download Created with Sketch. 185.76KB
ZLD Appendix 4C - quarterly
30/01/19PRICE SENSITIVE download Created with Sketch. 160.1KB
ZLD December 2018 Quarterly Report and Board Transition
30/01/19PRICE SENSITIVE download Created with Sketch. 199.72KB
ZLD Notice of General Meeting
18/01/19 download Created with Sketch. 153.55KB
ZLD Appendix 3B
16/01/19 download Created with Sketch. 344.47KB
ZLD Response to ASX Appendix 3Y Query
16/01/19 download Created with Sketch. 298.8KB
ZLD Change in substantial holding
14/01/19 download Created with Sketch. 162.18KB
ZLD Change of Director's Interest Notice
14/01/19 download Created with Sketch. 184.59KB
ZLD Response to ASX Price and Volume Query
08/01/19PRICE SENSITIVE download Created with Sketch. 297.5KB
ZLD Change of Director's Interest Notice
14/12/18 download Created with Sketch. 185.64KB
ZLD Change of Director's Interest Notice
07/12/18 download Created with Sketch. 197.17KB
ZLD ZLD to Invest in Development of Oral Spray Formulations
06/12/18PRICE SENSITIVE download Created with Sketch. 165.27KB
ZLD SUD: SUDA Enters Agreement To Develop Cannabinoid Spray
06/12/18PRICE SENSITIVE download Created with Sketch. 157.53KB
ZLD Results of Meeting
30/11/18 download Created with Sketch. 180.33KB
ZLD Annual General Meeting Presentation 2018
30/11/18 download Created with Sketch. 8.77MB
ZLD Investor Presentation - Non-deal Roadshow
27/11/18 download Created with Sketch. 8.77MB
ZLD Opioid reduction clinical trial with St Vincent's Hospital
26/11/18PRICE SENSITIVE download Created with Sketch. 131.23KB
ZLD Appendix 3B
22/11/18 download Created with Sketch. 336.16KB
ZLD Correction to Unlisted Option Expiry Date
14/11/18 download Created with Sketch. 153.71KB
ZLD Release From Escrow and Founders Commitment Not to Sell
07/11/18 download Created with Sketch. 163.35KB
ZLD Appendix 4C - quarterly
31/10/18PRICE SENSITIVE download Created with Sketch. 160.02KB
ZLD September 2018 Quarterly Report
31/10/18PRICE SENSITIVE download Created with Sketch. 228.73KB
ZLD Notice of Annual General Meeting
29/10/18 download Created with Sketch. 217.92KB
ZLD Managing Director Remuneration Variation
12/10/18 download Created with Sketch. 158.11KB
ZLD Zelda Focuses Clinical Trial Activity
11/10/18PRICE SENSITIVE download Created with Sketch. 157.83KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
38.0¢
Change
-0.030(7.32%)
Mkt cap ! $4.520M
Open High Low Value Volume
40.0¢ 42.0¢ 38.0¢ $1.766K 4.48K

Buyers (Bids)

No. Vol. Price($)
3 34234 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 5666 1
View Market Depth
Last trade - 15.50pm 15/09/2025 (20 minute delay) ?
Last
38.0¢
  Change
-0.030 ( 1.30 %)
Open High Low Volume
38.0¢ 38.0¢ 38.0¢ 1184
Last updated 14.55pm 15/09/2025 ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.